ATE416386T1 - Verwendung einer reinen allergenkomponente - Google Patents

Verwendung einer reinen allergenkomponente

Info

Publication number
ATE416386T1
ATE416386T1 AT01273004T AT01273004T ATE416386T1 AT E416386 T1 ATE416386 T1 AT E416386T1 AT 01273004 T AT01273004 T AT 01273004T AT 01273004 T AT01273004 T AT 01273004T AT E416386 T1 ATE416386 T1 AT E416386T1
Authority
AT
Austria
Prior art keywords
allergen component
pure allergen
pure
component
sensitizer
Prior art date
Application number
AT01273004T
Other languages
English (en)
Inventor
Sabine Stumvoll
Jonas Lidholm
Kerstin Westritschnig
S Spitzauer
Dietrich Kraft
D Geraci
Rudolf Valenta
P Colombo
G Duro
Original Assignee
Phadia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phadia Ab filed Critical Phadia Ab
Application granted granted Critical
Publication of ATE416386T1 publication Critical patent/ATE416386T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01273004T 2000-12-29 2001-12-27 Verwendung einer reinen allergenkomponente ATE416386T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004891A SE0004891D0 (sv) 2000-12-29 2000-12-29 Use of a pure allergen component

Publications (1)

Publication Number Publication Date
ATE416386T1 true ATE416386T1 (de) 2008-12-15

Family

ID=20282466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01273004T ATE416386T1 (de) 2000-12-29 2001-12-27 Verwendung einer reinen allergenkomponente

Country Status (11)

Country Link
EP (1) EP1352246B1 (de)
JP (1) JP4116881B2 (de)
AT (1) ATE416386T1 (de)
AU (1) AU2002217698B2 (de)
CA (1) CA2429672C (de)
DE (1) DE60136851D1 (de)
DK (1) DK1352246T3 (de)
ES (1) ES2316418T3 (de)
SE (1) SE0004891D0 (de)
SI (1) SI1352246T1 (de)
WO (1) WO2002054082A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662080B1 (de) * 1992-09-21 1997-02-05 C.B.F. Leti, S.A. Verfahren zur reinigung von waessrigen extrakten, die allergenische proteine enthalten, so erhaltene extrakte und ihre verwendung
CA2154379A1 (en) * 1994-07-22 1996-01-23 Shyam S. Mohapatra Parietaria allergens
US5786161A (en) * 1996-06-06 1998-07-28 Miltenyi Biotec. Gmbh Isolation and characterization of allergen-binding cells for diagnosis of hypersensitivity
WO1999051988A1 (en) * 1998-04-08 1999-10-14 Heska Corporation Method to detect biologically active, allergen-specific immunoglobulins

Also Published As

Publication number Publication date
ES2316418T3 (es) 2009-04-16
CA2429672A1 (en) 2002-07-11
WO2002054082A1 (en) 2002-07-11
EP1352246B1 (de) 2008-12-03
SE0004891D0 (sv) 2000-12-29
DE60136851D1 (de) 2009-01-15
JP2004523741A (ja) 2004-08-05
WO2002054082A8 (en) 2004-04-08
JP4116881B2 (ja) 2008-07-09
CA2429672C (en) 2010-09-21
DK1352246T3 (da) 2009-03-30
EP1352246A1 (de) 2003-10-15
SI1352246T1 (sl) 2009-04-30
AU2002217698B2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
TR200400815T3 (tr) AtorvastatinÁyarı@kalsiyumunÁyeniÁkristalÁformlarıÁveÁbunlarınÁhazırlanmasıÁiçinÁişlemlerÁayrıcaÁdiğerÁformlarınÁhazırlanmasıÁiçinÁyeniÁişlemler
ATE314354T1 (de) Radiopharmazeutika für die diagnose von alzheimer
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
AT500379B1 (de) Tau-proteine
TNSN01047A1 (fr) Procede pour la preparation de derives de piperazine nouveaux
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
ATE355293T1 (de) Substituierte 7-aza-(2.2.1)bicycloheptane für die behandlung von krankheiten
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
ATE345331T1 (de) Verbindungen verwendbar für die behandlung von entzündungskrankheiten
TNSN02008A1 (fr) Derives d'acides isophtalique nouveaux inhibiteurs de mmp, et compositions les contenant
CY1110322T1 (el) Αναστολεις της her3 δραστικοτητας
PA8552501A1 (es) 1-alquil o 1-cicloalquil-triazolo[4,3-a]quinazolin-5-onas como inhibidoras de fosfodiesterasa
DE60239558D1 (de) Kombinationen für die behandlung von immun-entzündlichen erkrankungen
ATE390485T1 (de) Irak-4 zusammensetzungen und deren verwendungen
DE60012140D1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
EP1448056A4 (de) Surfactant-protein d für die vorbeugung und diagnose von lungenemphysem
DE60136851D1 (de) Verwendung einer reinen allergenkomponente
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
JP2004170290A5 (de)
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
EA200400751A1 (ru) Применение дезоксипеганина для лечения клинической депрессии
DE60204269D1 (de) Zutat für Säuglingsmilchnahrung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties